SMN1 and Down syndrome: The neuromuscular gene panel (including sequencing and deletion/duplication analysis) (Invitae, United States) revealed a pathogenic homozygous deletion of entire coding sequence of the SMN1 gene and presence of 2 copies of the SMN2. Based on clinical evaluation and genetic studies, a dual diagnosis of Down syndrome and 5q-SMA were made.